UA89180C2 - Дроспиренон для гормональной заместительной терапии - Google Patents

Дроспиренон для гормональной заместительной терапии

Info

Publication number
UA89180C2
UA89180C2 UAA200612100A UAA200612100A UA89180C2 UA 89180 C2 UA89180 C2 UA 89180C2 UA A200612100 A UAA200612100 A UA A200612100A UA A200612100 A UAA200612100 A UA A200612100A UA 89180 C2 UA89180 C2 UA 89180C2
Authority
UA
Ukraine
Prior art keywords
drospirenone
estrogene
replacement therapy
hormone replacement
active component
Prior art date
Application number
UAA200612100A
Other languages
English (en)
Ukrainian (uk)
Inventor
Вольфганг ХАЙЛЬ
Юрген ХИЛЬМАН
Ральф Липп
Рольф Шюрманн
Original Assignee
Байер Шеринг Фарма Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезелльшафт filed Critical Байер Шеринг Фарма Акциенгезелльшафт
Publication of UA89180C2 publication Critical patent/UA89180C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200612100A 2000-01-18 2001-01-18 Дроспиренон для гормональной заместительной терапии UA89180C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200183 2000-01-18

Publications (1)

Publication Number Publication Date
UA89180C2 true UA89180C2 (ru) 2010-01-11

Family

ID=38170612

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200612100A UA89180C2 (ru) 2000-01-18 2001-01-18 Дроспиренон для гормональной заместительной терапии
UA2002086809A UA81388C2 (en) 2000-01-18 2001-01-18 Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy

Family Applications After (1)

Application Number Title Priority Date Filing Date
UA2002086809A UA81388C2 (en) 2000-01-18 2001-01-18 Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy

Country Status (7)

Country Link
AR (1) AR035633A1 (ru)
CO (1) CO5280075A1 (ru)
HR (1) HRP20070360B1 (ru)
JO (1) JO2334B1 (ru)
PE (1) PE20011051A1 (ru)
SA (1) SA01210754B1 (ru)
UA (2) UA89180C2 (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
DE19654609A1 (de) * 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
EP2044941A1 (en) * 1999-08-31 2009-04-08 Bayer Schering Pharma AG Multiple-phase formulation of drospirenone and estradiol as a contraceptive

Also Published As

Publication number Publication date
HRP20070360B1 (hr) 2014-11-21
UA81388C2 (en) 2008-01-10
JO2334B1 (en) 2006-06-28
SA01210754B1 (ar) 2007-02-17
PE20011051A1 (es) 2001-10-17
AR035633A1 (es) 2004-06-23
HRP20070360A2 (en) 2008-12-31
CO5280075A1 (es) 2003-05-30

Similar Documents

Publication Publication Date Title
YU54602A (sh) Drospirenon za terapiju zamene hormona
EA200201000A1 (ru) Гормон-заместительная терапия
RO115115B1 (ro) Terapie prin inlocuire hormonala
HK1054332A1 (zh) 具有全身效應的新型局部雌激素孕激素組合物
IL122432A (en) Transdermal patch for preventing ovulation
WO2006053172A3 (en) The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases
SG153645A1 (en) Hormone replacement therapy
HRP20030387A2 (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
EP1796725B1 (en) Treatment or prevention of unscheluded bleeding in women on progestogen containing medication
US20120225853A1 (en) Hormone replacement therapy and depression
UA89180C2 (ru) Дроспиренон для гормональной заместительной терапии
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
Saure et al. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol–progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
HRP20020666A8 (en) Drospirenone for hormone replacement therapy
EA007840B1 (ru) Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента композиций для заместительной гормональной терапии (згт)
WO2000067708A3 (en) Oral steroidal hormone compositions and methods of use
CA2421302A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
Oelkers The renin–aldosterone system and drospirenone
UY26539A1 (es) Drospirenona para terapia de reemplazo de hormonas.
CA2388237A1 (en) Treatment of osteoporosis
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
AU5942700A (en) Sequential estrogen/progestrone antagonist combination for hormone replacement theapy
de Gaetano et al. Cardiovascular Disease: Risk Factors Related to Thrombosis
MXPA98007513A (en) Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo